| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 60,881 | 59,111 | 56,016 | 62,723 | | Cost of Revenue | (30,531) | 15,483 | 15,048 | 68,538 | | | Gross Profit | 91,412 | 43,628 | 40,968 | (5,815) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 51,176 | 5,136 | 3,983 | (48,570) | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 167 | 165 | 173 | 165 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 20,478 | 38,327 | 36,812 | 42,590 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 30,370 | 2,805 | 4,834 | (142,638) | | Earnings Before Interest And Taxes | 39,081 | 38,327 | 36,812 | 42,590 | | Interest Expense | 5,721 | 6,301 | 6,581 | 9,902 | | Income Before Tax | 33,360 | 32,026 | 30,231 | 32,688 | | Income Tax Expense | 454 | 78 | 31 | 550 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 51,810 | 34,753 | 35,034 | (110,500) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 63,276 | 34,753 | 35,034 | (110,500) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $63,276 | $34,753 | $35,034 | ($110,500) |
|
0.51% Nasdaq 
Income Statement
